SCHEMBL24174696

SCHEMBL24174696

Fc1c(I)cc(Cl)nc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30415941 1.00
SCHEMBL23152571 0.81
SCHEMBL23673410 0.77 ALDH1A1 (0.32)
SCHEMBL30599213 0.77 ALDH1A1 (0.32)
SCHEMBL25136990 0.77
SCHEMBL24174525 0.77 SMN1; SMN2 (0.38)
SCHEMBL31258769 0.74
SCHEMBL31258708 0.73 KHK (0.37)
SCHEMBL18260463 0.71 TDP1 (0.44)
SCHEMBL19356946 0.71 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024182551-A1 LZK INHIBITORS UEREKA BIOSCIENCES, INC. (US) 2024-09-06 WO disclosed
US-20230339927-A1 ATR INHIBITORS AND USES THEREOF ANTENGENE DISCOVERY LIMITED (CN) 2023-10-26 US disclosed
US-20230339927-A1 ATR INHIBITORS AND USES THEREOF ANTENGENE DISCOVERY LIMITED (CN) 2023-10-26 US disclosed
CN-116134022-A ATR inhibitors and uses thereof 上海德琪医药科技有限公司 2023-05-16 CN disclosed
WO-2022002245-A1 ATR INHIBITORS AND USES THEREOF SHANGHAI ANTENGENE CORPORATION LIMITED (CN) 2022-01-06 WO disclosed